[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-362178-105":59,"doc-detail-362178-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","distinct-mechanisms-of-cell-in-breast-cancer-and-their-clinical-implication-review","Distinct mechanisms of cell in breast cancer and their clinical implication - review","","Breast cancer is a heterogeneous disease affecting women globally. Despite therapeutic advances, it remains a leading cause of cancer-related morbidity, driven by diverse molecular subtypes and growing complexity in targeted treatments. Dysregulated apoptosis and suppressed cell death are key hallmarks of malignant tumors. The obstruction of apoptosis and the broader spectrum of cell-death modalities, including apoptosis and other regulated death forms, motivates the search for new therapeutic targets.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/distinct-mechanisms-of-cell-in-breast-cancer-and-their-clinical-implication-review/362178/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/distinct-mechanisms-of-cell-in-breast-cancer-and-their-clinical-implication-review/362178.png","ImageObject",300,407,{"name":92,"@type":93},"Riley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-17","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is breast cancer still a major health burden despite recent treatment progress?","Question",{"text":112,"@type":113},"Breast cancer is highly heterogeneous, with diverse molecular subtypes and increasing complexity in targeted therapies, so effective interventions remain challenging and morbidity stays high.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What cell-death events are highlighted as critical in tumorigenesis?",{"text":117,"@type":113},"The article emphasizes apoptosis obstruction and suppressed cell death, and notes a spectrum of modalities including apoptosis, anoikis, autophagy, necroptosis, ferroptosis, pyroptosis, and cuproptosis.",{"name":119,"@type":110,"acceptedAnswer":120},"How does the review connect mechanisms of cell death to clinical management?",{"text":121,"@type":113},"It systematically analyzes molecular underpinnings of cell-death pathways in breast cancer and links mechanistic insights to therapeutic opportunities that can inform clinical strategies.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},362178,1791482311,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","Cell Biol Toxicol (2026) 42:12  \n[https://doi.org/10.1007/s10565-025-10104-9](https://doi.org/10.1007/s10565-025-10104-9)  \nDistinct mechanisms of cell in breast cancer and their clinical implication  \nAodi Li · Sishi Liu · Ying Xuan · Ying Liang · Lei Wang · Lei Zhao  \nReceived: 30 June 2025 / Accepted: 24 September 2025  \n© The Author(s) 2025  \nAbstract Breast cancer is a heterogeneous disease affecting women globally. Despite significant advancements in therapeutic interventions in recent years, breast cancer remains a leading cause of cancer-related morbidity in women. Breast cancer’s diverse molecular subtypes and escalating complexities in targeted therapies underscore the imperative need to explore novel therapeutic targets. The obstruction of apoptosis and the suppression of cell death are hallmarks of malignant tumors. Cell death,  \nAodi Li, Sishi Liu, and Ying Xuan contributed equally to this work.  \nA. Li · L. Zhao (*)  \nDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning Province, China  \ne-mail: [zhaolei@cmu.edu.cn](zhaolei@cmu.edu.cn)  \n[S. Liu](S. Liu)  \nDepartment of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, China  \nY. Xuan  \nDepartment of Oncology, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, China  \nY. Liang (*) · L. Wang (*)  \nDepartment of Hematology, The First Hospital of China Medical University, Shenyang, Liaoning Province, China  \ne-mail: [yliang@cmu.edu.cn](yliang@cmu.edu.cn)  \n[L. Wang](L. Wang)  \ne-mail: [leiwen000@sina.com.cn](leiwen000@sina.com.cn)  \na pivotal regulatory event during tumorigenesis, includes apoptosis, anoikis, autophagy, necroptosis, ferroptosis, pyroptosis, and cuproptosis. This review systematically dissects the molecular underpinnings of cell death pathways in breast cancer, offering novel mechanistic insights and therapeutic opportunities to inform clinical management strategies.  \nKeywords Breast cancer · Cell death · Ferroptosis · Pyroptosis · Cuproptosis  \nIntroduction  \nBreast cancer represents a prevalent malignancy globally, accounting for the highest cancer-related mortality rate among females (Bray et al. 2024) . Given its high heterogeneity, molecular classification primarily hinges on the expression profiles of the progesterone receptor (PR), estrogen receptor (ER), and human epidermal growth factor receptor 2 (HER2) (Perou et al. 2000) . Tumors exhibiting robust ER or PR expression are categorized as hormone-positive (ER +, PR +), while those characterized by HER2 overexpression are classified as HER2-positive (HER2 +) (Faria et al. 2021) . Triple-negative breast cancer (TNBC) is defined by the absence of ER/PR and HER2 expression, constituting approximately 15–20% of breast malignancies and presenting a 40% mortality rate within 5-year post-diagnosis (Sharma et al. 2019) .  \nTNBC exhibits a high risk of recurrence, attributed to its aggressive invasive potential, metastatic propensity, and infiltrated blood vessels (Cui et al. 2021) . Compared to other breast cancer subtypes, the prognosis for TNBC is relatively unfavorable and presents significantly limited treatment options owing to the absence of ER, PR, and HER2 expression (Loi et al. 2013) .  \nData from 185 countries collected by the International Agency for Research on Cancer (IARC) for GLOBOCAN 2020, revealed 2.3 million new cases of breast cancer, accounting for 11.7% of all cancer cases. Furthermore, breast cancer was associated with a mortality rate of 6.9% among recorded cases (Sunget al. 2021) . It also demonstrates an age-dependent incidence, with older women disproportionately affected. Estimations show that the number of new instances of breast cancer and associated mortality in the United States was 0.28 million and 0.04 million, respectively (Siegel et al. 2021) . In 2018, 645,000 cases and 1.4 million cases of breast cancer were reported in the premenopausal a","cbCaisXxNX2dwLnl","https://ap.wps.com/l/cbCaisXxNX2dwLnl","pdf",3537309,27,"English","# Abstract\n# Introduction\n## Molecular subtypes and clinical relevance\n## Global burden and epidemiology\n## Cell death categories and regulated cell death\n# Review focus","[{\"question\":\"Why is breast cancer still a major health burden despite recent treatment progress?\",\"answer\":\"Breast cancer is highly heterogeneous, with diverse molecular subtypes and increasing complexity in targeted therapies, so effective interventions remain challenging and morbidity stays high.\"},{\"question\":\"What cell-death events are highlighted as critical in tumorigenesis?\",\"answer\":\"The article emphasizes apoptosis obstruction and suppressed cell death, and notes a spectrum of modalities including apoptosis, anoikis, autophagy, necroptosis, ferroptosis, pyroptosis, and cuproptosis.\"},{\"question\":\"How does the review connect mechanisms of cell death to clinical management?\",\"answer\":\"It systematically analyzes molecular underpinnings of cell-death pathways in breast cancer and links mechanistic insights to therapeutic opportunities that can inform clinical strategies.\"}]","Distinct mechanisms of cell in breast cancer and their clinical implication - review | PDF",1790146665,68,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d7911c8e4c740e29a0e996f80ab648be.webp",983,1324,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c3d4f343222ff5bdb46f76ec6efaa327.webp",982,1322,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9dbaf71d54aa49150ebcb0f60a37c79c.webp",981,1321,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/094933fa48e87e039a1d8b3872f6fb2b.webp",980,1319]